Trial Profile
Efficacy, tolerability, and immunogenicity of botulinum toxin A for torticollis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Sep 2012
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- 27 Sep 2012 New trial record
- 31 Aug 2012 The primary endpoints Cervical Dystonia Severity Scale and Physician Global Assessment have been met.
- 31 Aug 2012 Results published in the Clinical Neuropharmacology.